A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma
Clinical trial NCT04251416 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04251416
- Sponsor
- Yale University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-17
- Primary completion
- 2026-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.